Details of Drug

Drug General Information (ID: D0115)
Drug Name	Astemizole
Drug Type	Small molecule
Drug Synonymous	Alermizol; Astemina; Astemisan; Astemisol; Astemison; Astemizol; Astemizolum; Astesen; Emdar; Esmacen; Fustermizol; Hestazol; Hismanal; Histamen; Histaminos; Histazol; Hubermizol; Kelp; Laridal; Metodih; Metodik; Paralergin; Retolen; Rifedot; Rimbol; Romadin; Simprox; Urdrim; Wareezol; Waruzol; AlacanBrand of Astemizole; Alonga Brand of Astemizole; Astemizol Alonga; Astemizol [German]; Astemizol ratiopharm; Astemizole Alacan Brand; Astemizole Alonga Brand; Astemizole Byk Brand; Astemizole Diba Brand; Astemizole Elfar Brand; Astemizole Esteve Brand; Astemizole Fustery Brand; Astemizole ICN Brand; Astemizole Janssen Brand; Astemizole Lesvi Brand; Astemizole McNeil Brand; Astemizole Medinsa Brand; Astemizole Merck Brand; Astemizole Senosiain Brand; Astemizole Septa Brand; Astemizole Smaller Brand; Astemizole Urbion Brand; Astemizole Vita Brand; Astemizole ratiopharm Brand; Byk Brand of Astemizole; Diba Brand of Astemizole; Elfar Brand of Astemizole; Esteve Brand of Astemizole; Fustery Brand of Astemizole; ICN Brand of Astemizole; Janssen Brand of Astemizole; Lesvi Brand of Astemizole; McNeil Brand of Astemizole; Medinsa Brand of Astemizole; Merck Brand of Astemizole; Ratiopharm Brand of Astemizole; Reig Jofre Brand of Astemizole; Senosiain Brand of Astemizole; Septa Brand of Astemizole; Smaller Brand of Astemizole; Urbion Brand of Astemizole; Vita Brand of Astemizole; R 42512; [3H]Astemizole; Alonga, Astemizol; Astemizol [INN-Spanish]; Astemizolum [INN-Latin]; HISMANAL (TN); Hismanal (TN); MJD-30; Nono-Nastizol A; Novo-mastizol A; Ratiopharm, Astemizol; Astemizole [USAN:BAN:INN]; GNF-PF-2461; Astemizole (JAN/USP/INN); Hestazol, Kelp, Laridal, Retolen, Wareezol, HSBD 6799, BRN 4830190; 1-(p-Fluorobenzyl)-2-((1-(p-methoxyphenethyl)-4-piperidyl)amino)benzimidazole Click to Show/Hide
Disease Class	CA08: Vasomotor/allergic rhinitis
Therapeutic Class	Antiallergic Agents
Structure
Structure	3D Structure		2D Structure
Formula	C28H31FN4O
InChI	1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)
InChIKey	GXDALQBWZGODGZ-UHFFFAOYSA-N
Canonical SMILES	COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F
External Link
	Pubchem ID	2247
	CAS Number	68844-77-9
	CHEBI ID	2896
	TTD ID	D0Y2HR
	INTEDE ID	DR0147
	VARIDT ID	DR00705

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM002 Affected cellular transport AM003 Affected organization distribution AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM010 Transporter inhibition BM014 Interference of cell/tissue uptake BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM024 Competitive inhibition of metabolic enzyme BM038 Additive CNS depression effects BM042 Additive hypotensive effects BM049 Increased risk of atrioventricular block BM076 Increased risk of prolong QT interval BM081 Increased risk of ventricular arrhythmias BM106 Diminish the response to diagnostic skin test antigens BM107 Attenuated pharmacological effects (Unspecific)
Relation Graph

Full list of drugs interacting with Astemizole
Affected cellular transport
	Transporter inhibition					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0182		Binimetinib	C17H15BrF2N4O3	10288191	Moderate		Inter Info	[2], [3], [266]
D0963		Lusutrombopag	C29H32Cl2N2O5S	49843517	Moderate		Inter Info	[21]
D0658		Fidaxomicin	C52H74Cl2O18	10034073	Minor		Inter Info	[2], [3], [392]
Affected organization distribution
	Interference of cell/tissue uptake					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1822		Iodide I-123	I-	135300	Moderate		Inter Info	[299], [162], [300]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 52
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0080		Amprenavir	C25H35N3O6S	65016	Major		Inter Info	[23], [24], [25]
D0100		Aprepitant	C23H21F7N4O3	135413536	Major		Inter Info	[26], [27]
D0116		Atazanavir	C38H52N6O7	148192	Major		Inter Info	[30], [31], [32], [33], [34], [35], [36], [23], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [24], [60], [61], [62], [25], [63], [64], [65]
D0349		Clarithromycin	C38H69NO13	84029	Major		Inter Info	[30], [69], [31], [70], [71], [72], [40], [73], [43], [74], [75], [48], [76], [77]
D0386		Conivaptan	C32H26N4O2	151171	Major		Inter Info	[30], [31], [32], [33], [34], [35], [23], [37], [38], [39], [40], [41], [42], [44], [46], [47], [48], [49], [78], [59], [24], [60], [61], [62], [25], [63], [64], [65]
D0413		Dalfopristin	C34H50N4O9S	6323289	Major		Inter Info	[80], [42], [81]
D0426		Darunavir	C27H37N3O7S	213039	Major		Inter Info	[30], [31], [32], [33], [34], [35], [36], [23], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [24], [60], [61], [62], [25], [63], [64], [65]
D0439		Delavirdine	C22H28N6O3S	5625	Major		Inter Info	[80], [42], [82]
D0692		Fosamprenavir	C25H36N3O9PS	131536	Major		Inter Info	[30], [31], [32], [33], [34], [35], [36], [23], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [24], [60], [61], [62], [25], [63], [64], [65]
D0693		Fosaprepitant	C23H22F7N4O6P	135413538	Major		Inter Info	[26], [27]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Major		Inter Info	[30], [112], [2], [32], [34], [113], [38], [114], [115], [116], [76], [117], [118], [119], [120], [24], [121], [60], [122], [61], [62], [25], [123], [63], [64]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Major		Inter Info	[30], [112], [2], [32], [34], [113], [38], [114], [115], [116], [76], [117], [118], [119], [120], [24], [121], [60], [122], [61], [62], [25], [123], [63], [64]
D0899		Lefamulin	C28H45NO5S	25185057	Major		Inter Info	[128], [129], [130]
D1057		Miconazole	C18H14Cl4N2O	4189	Major		Inter Info	[30], [112], [2], [32], [34], [113], [38], [114], [115], [116], [76], [117], [118], [119], [120], [24], [121], [60], [122], [61], [62], [25], [123], [63], [64]
D1063		Mifepristone	C29H35NO2	55245	Major		Inter Info	[134], [135], [136]
D1117		Nefazodone	C25H32ClN5O2	4449	Major		Inter Info	[137]
D1229		Paroxetine	C19H20FNO3	43815	Major		Inter Info	[149], [150], [151]
D1315		Posaconazole	C37H42F2N8O4	468595	Major		Inter Info	[30], [112], [2], [32], [34], [113], [38], [114], [115], [116], [76], [117], [118], [119], [120], [24], [121], [60], [122], [61], [62], [25], [123], [63], [64]
D1444		Saquinavir	C38H50N6O5	441243	Major		Inter Info	[30], [31], [32], [33], [34], [35], [36], [23], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [24], [60], [61], [62], [25], [63], [64], [65]
D1461		Sertraline	C17H17Cl2N	68617	Major		Inter Info	[149], [150], [151]
D1544		Telithromycin	C43H65N5O10	3002190	Major		Inter Info	[30], [70], [43]
D0337		Cimetidine	C10H16N6S	2756	Major		Inter Info	[39], [168], [47], [169], [170]
D0367		Clotrimazole	C22H17ClN2	2812	Major		Inter Info	[30], [112], [2], [32], [34], [113], [38], [114], [115], [116], [76], [117], [118], [119], [120], [24], [121], [60], [122], [61], [62], [25], [123], [63], [64]
D0554		Efavirenz	C14H9ClF3NO2	64139	Major		Inter Info	[176]
D0597		Erythromycin	C37H67NO13	12560	Major		Inter Info	[30], [69], [31], [70], [71], [72], [40], [73], [43], [74], [75], [48], [76], [77]
D0667		Fluconazole	C13H12F2N6O	3365	Major		Inter Info	[30], [112], [2], [32], [34], [113], [38], [114], [115], [116], [76], [117], [118], [119], [120], [24], [121], [60], [122], [61], [62], [25], [123], [63], [64]
D0676		Fluoxetine	C17H18F3NO	3386	Major		Inter Info	[149], [150], [151]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Major		Inter Info	[177], [151]
D0799		Indinavir	C36H47N5O4	5362440	Major		Inter Info	[30], [31], [32], [33], [34], [35], [36], [23], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [24], [60], [61], [62], [25], [63], [64], [65]
D1119		Nelfinavir	C32H45N3O4S	64143	Major		Inter Info	[30], [31], [32], [33], [34], [35], [36], [23], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [24], [60], [61], [62], [25], [63], [64], [65]
D1372		Quinine	C20H24N2O2	3034034	Major		Inter Info	[215], [76]
D1415		Ritonavir	C37H48N6O5S2	392622	Major		Inter Info	[30], [31], [32], [33], [34], [35], [36], [23], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [24], [60], [61], [62], [25], [63], [64], [65]
D1706		Voriconazole	C16H14F3N5O	71616	Major		Inter Info	[30], [112], [2], [32], [34], [113], [38], [114], [115], [116], [76], [117], [118], [119], [120], [24], [121], [60], [122], [61], [62], [25], [123], [63], [64]
D0002		Abametapir (topical)	C12H12N2	15664	Moderate		Inter Info	[220]
D0432		Deferasirox	C21H15N3O4	214348	Moderate		Inter Info	[277], [278]
D0543		Duvelisib	C22H17ClN6O	50905713	Moderate		Inter Info	[283]
D0638		Fedratinib	C27H36N6O3S	16722836	Moderate		Inter Info	[3], [291]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[292]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[298]
D0852		Isavuconazonium	C35H35F2N8O5S+	6918606	Moderate		Inter Info	[3], [301]
D0869		Ivacaftor	C24H28N2O3	16220172	Moderate		Inter Info	[302]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Moderate		Inter Info	[2], [3], [303]
D0906		Letermovir	C29H28F4N4O4	45138674	Moderate		Inter Info	[304]
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Moderate		Inter Info	[314]
D1167		Olaparib	C24H23FN4O3	23725625	Moderate		Inter Info	[2], [3]
D1214		Palbociclib	C24H29N7O2	5330286	Moderate		Inter Info	[322]
D1579		Ticagrelor	C23H28F2N6O4S	9871419	Moderate		Inter Info	[3], [352]
D1660		Tucatinib	C26H24N8O2	51039094	Moderate		Inter Info	[360], [361], [362]
D1709		Voxelotor	C19H19N3O3	71602803	Moderate		Inter Info	[364], [347], [365]
D1721		Zileuton	C11H12N2O2S	60490	Moderate		Inter Info	[366]
D0497		Diltiazem	C22H26N2O4S	39186	Moderate		Inter Info	[370], [371], [372], [373], [374]
D0793		Imatinib	C29H31N7O	5291	Moderate		Inter Info	[375]
	CYP450 enzyme induction					Drug Num: 17
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0204		Brigatinib	C29H39ClN7O2P	68165256	Moderate		Inter Info	[271]
D0300		Cenobamate	C10H10ClN5O2	11962412	Moderate		Inter Info	[272]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[3], [275]
D0545		Echinacea	NA	NA	Moderate		Inter Info	[2], [284]
D0590		Erdafitinib	C25H30N6O2	67462786	Moderate		Inter Info	[287]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[289]
D0953		Lorlatinib	C21H19FN6O2	71731823	Moderate		Inter Info	[317]
D1190		Osimertinib	C28H33N7O2	71496458	Moderate		Inter Info	[3], [321]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Moderate		Inter Info	[323], [324]
D1401		Rifapentine	C47H64N4O12	135403821	Moderate		Inter Info	[341], [342]
D1538		Tazemetostat	C34H44N4O4	66558664	Moderate		Inter Info	[347], [348]
D1546		Telotristat ethyl	C27H26ClF3N6O3	25181577	Moderate		Inter Info	[3], [349]
D0178		Bexarotene	C24H28O2	82146	Moderate		Inter Info	[3], [367], [368]
D0194		Bosentan	C27H29N5O6S	104865	Moderate		Inter Info	[369]
D1128		Nevirapine	C15H14N4O	4463	Moderate		Inter Info	[2], [3], [379], [380]
D0106		Armodafinil	C15H15NO2S	9690109	Minor		Inter Info	[387], [388], [389], [390], [391]
D1081		Modafinil	C15H15NO2S	4236	Minor		Inter Info	[387], [388], [389], [390], [391]
	Competitive inhibition of metabolic enzyme					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1127		Netupitant	C30H32F6N4O	6451149	Moderate		Inter Info	[2], [318], [319]
D1476		Sirolimus	C51H79NO13	5284616	Moderate		Inter Info	[344], [345]
D1549		Temsirolimus	C56H87NO16	6918289	Moderate		Inter Info	[344], [345]
Pharmacodynamic additive effects
	Additive CNS depression effects					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0452		Deutetrabenazine	C19H27NO3	73437646	Moderate		Inter Info	[279]
D1673		Valbenazine	C24H38N2O4	24795069	Moderate		Inter Info	[363]
	Additive hypotensive effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0942		Lofexidine	C11H12Cl2N2O	30668	Moderate		Inter Info	[1], [2], [3], [313], [21]
	Increased risk of atrioventricular block					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0992		Mefloquine	C17H16F6N2O	4046	Moderate		Inter Info	[3], [376], [377]
	Increased risk of prolong QT interval					Drug Num: 149
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0084		Anagrelide	C10H7Cl2N3O	135409400	Major		Inter Info	[1], [2], [3], [4]
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[1], [2], [3], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21]
D0067		Amisulpride	C17H27N3O4S	2159	Major		Inter Info	[22]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Major		Inter Info	[66]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[3], [67]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[1], [2], [3], [68]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[79]
D0514		Dolasetron	C19H20N2O3	3033818	Major		Inter Info	[1], [2], [3], [83]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[1], [2], [3], [84]
D0599		Escitalopram	C20H21FN2O	146570	Major		Inter Info	[1], [85], [2], [3], [86], [87], [21]
D0712		Gatifloxacin	C19H22FN3O4	5379	Major		Inter Info	[90], [1], [91]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Major		Inter Info	[92], [3], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[1], [2], [3], [111], [21]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Major		Inter Info	[126], [127]
D0960		Lumefantrine	C30H32Cl3NO	6437380	Major		Inter Info	[2], [3], [131]
D0965		Macimorelin	C26H30N6O3	9804938	Major		Inter Info	[132]
D1010		Mesoridazine	C21H26N2OS2	4078	Major		Inter Info	[2], [3], [133]
D1136		Nilotinib	C28H22F3N7O	644241	Major		Inter Info	[1], [2], [3], [138]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[140]
D1223		Papaverine	C20H21NO4	4680	Major		Inter Info	[141], [142], [143], [144], [145], [146], [147], [148]
D1230		Pasireotide	C58H66N10O9	9941444	Major		Inter Info	[1], [2], [3], [152]
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[3], [156], [157], [21]
D1343		Procainamide	C13H21N3O	4913	Major		Inter Info	[1], [2], [3], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[1], [2], [3], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21]
D1398		Ribociclib	C23H30N8O	44631912	Major		Inter Info	[1], [2], [3], [156], [158], [159], [160], [21]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[161], [162]
D1574		Thioridazine	C21H26N2S2	5452	Major		Inter Info	[3], [164], [165]
D1681		Vandetanib	C22H24BrFN4O2	3081361	Major		Inter Info	[1], [2], [3], [166]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Major		Inter Info	[1], [2], [3], [167]
D0320		Chloroquine	C18H26ClN3	2719	Major		Inter Info	[92], [3], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[1], [2], [3], [171], [172], [21], [89]
D0370		Clozapine	C18H19ClN4	135398737	Major		Inter Info	[1], [2], [3], [173], [21]
D0508		Disopyramide	C21H29N3O	3114	Major		Inter Info	[1], [2], [3], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21]
D0513		Dofetilide	C19H27N3O5S2	71329	Major		Inter Info	[1], [2], [3], [174]
D0535		Droperidol	C22H22FN3O2	3168	Major		Inter Info	[1], [2], [3], [156], [175], [21]
D0750		Haloperidol	C21H23ClFNO2	3559	Major		Inter Info	[1], [2], [3], [178], [179], [180], [181], [182], [183], [21]
D0787		Ibutilide	C20H36N2O3S	60753	Major		Inter Info	[1], [2], [3], [184]
D1017		Methadone	C21H27NO	4095	Major		Inter Info	[1], [2], [3], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [21]
D1092		Moxifloxacin	C21H24FN3O4	152946	Major		Inter Info	[90], [195], [196], [1], [2], [3], [197], [198], [199], [200], [158], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [91], [212], [213], [214]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[216]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[1], [2], [3], [217]
D1726		Ziprasidone	C21H21ClN4OS	60854	Major		Inter Info	[1], [2], [3], [156], [218], [21]
D0036		Alfuzosin	C19H27N5O4	2092	Moderate		Inter Info	[1], [2], [3], [219], [21]
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0007		Abiraterone	C24H31NO	132971	Moderate		Inter Info	[3], [221], [222], [223], [224], [225], [226], [227]
D0095		Apalutamide	C21H15F4N5O2S	24872560	Moderate		Inter Info	[3], [221], [222], [223], [224], [225], [226], [227]
D0097		Apomorphine	C17H17NO2	6005	Moderate		Inter Info	[1], [2], [3], [228], [21]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[2], [3], [259], [260], [261], [262], [263], [264]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[1], [2], [3], [265], [21]
D0180		Bicalutamide	C18H14F4N2O4S	2375	Moderate		Inter Info	[3], [221], [222], [223], [224], [225], [226], [227]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Moderate		Inter Info	[3], [270]
D0219		Buprenorphine	C29H41NO4	644073	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0336		Cilostazol	C20H27N5O2	2754	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0358		Clofazimine	C27H22Cl2N4	2794	Moderate		Inter Info	[273], [120], [274]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[276]
D0429		Daunorubicin	C27H29NO10	30323	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Moderate		Inter Info	[158], [160], [21]
D0437		Degarelix	C82H103ClN18O16	16136245	Moderate		Inter Info	[3], [221], [222], [223], [224], [225], [226], [227]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0467		Dextropropoxyphene	C22H29NO2	10100	Moderate		Inter Info	[158], [160], [21]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0528		Doxorubicin	C27H29NO11	31703	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[285]
D0577		Entrectinib	C31H34F2N6O2	25141092	Moderate		Inter Info	[3], [286]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Moderate		Inter Info	[3], [221], [222], [223], [224], [225], [226], [227]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[1], [2], [3], [288]
D0632		Ezogabine	C16H18FN3O2	121892	Moderate		Inter Info	[158], [160], [21]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[2], [3], [290]
D0664		Flecainide	C17H20F6N2O3	3356	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0700		Fostemsavir	C25H26N7O8P	11319217	Moderate		Inter Info	[293]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Moderate		Inter Info	[195], [202], [203], [208], [294]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[295]
D0725		Glasdegib	C21H22N6O	25166913	Moderate		Inter Info	[296]
D0738		Granisetron	C18H24N4O	5284566	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0751		Halothane	C2HBrClF3	3562	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0758		Histrelin	C66H86N18O12	25077993	Moderate		Inter Info	[3], [221], [222], [223], [224], [225], [226], [227]
D0788		Idarubicin	C26H27NO9	42890	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0903		Lenvatinib	C21H19ClN4O4	9823820	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[195], [1], [2], [3], [199], [200], [158], [305], [306], [203], [204], [307], [205], [308], [206], [207], [208], [209], [309], [310], [311], [212], [312]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Moderate		Inter Info	[3]
D0940		Lithium carbonate	CLi2O3	11125	Moderate		Inter Info	[158], [160], [21]
D0947		Loperamide	C29H33ClN2O2	3955	Moderate		Inter Info	[315], [316]
D0979		Maprotiline	C20H23N	4011	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1137		Nilutamide	C12H10F3N3O4	4493	Moderate		Inter Info	[3], [221], [222], [223], [224], [225], [226], [227]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[2], [158], [310]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[195], [1], [2], [3], [199], [200], [158], [305], [306], [203], [204], [307], [205], [308], [206], [207], [208], [209], [309], [310], [311], [212], [312]
D1169		Oliceridine	C22H30N2O2S	66553195	Moderate		Inter Info	[158], [160], [21]
D1181		Ondansetron	C18H19N3O	4595	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1189		Osilodrostat	C13H10FN3	44139752	Moderate		Inter Info	[126], [320], [162]
D1215		Paliperidone	C23H27FN4O3	115237	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1232		Pazopanib	C21H23N7O2S	10113978	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1246		Pentamidine	C19H24N4O2	4735	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1257		Perphenazine	C21H26ClN3OS	4748	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1290		Pimavanserin	C25H34FN3O2	10071196	Moderate		Inter Info	[325]
D1339		Primaquine	C15H21N3O	4908	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1353		Propafenone	C21H27NO3	4932	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1356		Propofol	C12H18O	4943	Moderate		Inter Info	[327], [328], [329], [330], [331], [332], [333], [334], [335], [336]
D1368		Quetiapine	C21H25N3O2S	5002	Moderate		Inter Info	[1], [2], [3], [156], [337], [338], [339], [340], [21]
D1404		Rilpivirine	C22H18N6	6451164	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1413		Risperidone	C23H27FN4O2	5073	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1424		Romidepsin	C24H36N4O6S2	5352062	Moderate		Inter Info	[158], [160], [21]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1463		Sevoflurane	C4H3F7O	5206	Moderate		Inter Info	[1], [2], [3], [343]
D1491		Solifenacin	C23H26N2O2	154059	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[1], [2], [3], [346]
D1526		Tacrolimus	C44H69NO12	445643	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1533		Tamoxifen	C26H29NO	2733526	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1560		Tetrabenazine	C19H27NO3	6018	Moderate		Inter Info	[1], [2], [3], [350], [21]
D1596		Tizanidine	C9H8ClN5S	5487	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[353], [354], [259], [355], [356], [357], [21]
D1634		Triclabendazole	C14H9Cl3N2OS	50248	Moderate		Inter Info	[158], [160], [21]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1651		Triptorelin	C64H82N18O13	25074470	Moderate		Inter Info	[3], [221], [222], [223], [224], [225], [226], [227]
D1682		Vardenafil	C23H32N6O4S	135400189	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0119		Atomoxetine	C17H21NO	54841	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0139		Azithromycin	C38H72N2O12	447043	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0682		Flutamide	C11H11F3N2O3	3397	Moderate		Inter Info	[3], [221], [222], [223], [224], [225], [226], [227]
D0694		Foscarnet	CH3O5P	3415	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0737		Goserelin	C59H84N18O14	5311128	Moderate		Inter Info	[3], [221], [222], [223], [224], [225], [226], [227]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D0908		Leuprolide	C59H84N16O12	657181	Moderate		Inter Info	[3], [221], [222], [223], [224], [225], [226], [227]
D1075		Mirtazapine	C17H19N3	4205	Moderate		Inter Info	[378]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1166		Olanzapine	C17H20N4S	135398745	Moderate		Inter Info	[2], [3], [381]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1210		Oxytocin	C43H66N12O12S2	439302	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1216		Palonosetron	C19H24N2O	6337614	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1254		Perflutren	C3F8	6432	Moderate		Inter Info	[382], [383]
D1346		Prochlorperazine	C20H24ClN3S	4917	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1383		Ranolazine	C24H33N3O4	56959	Moderate		Inter Info	[384], [385]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Moderate		Inter Info	[1], [2], [3], [386]
D1616		Tramadol	C16H25NO2	33741	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1683		Vasopressin	C46H65N15O12S2	644077	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[1], [2], [3], [156], [158], [160], [21]
D1051		Metronidazole	C6H9N3O3	4173	Minor		Inter Info	[2], [395], [396], [397]
D1516		Sulfamethoxazole	C10H11N3O3S	5329	Minor		Inter Info	[1], [2], [398]
	Increased risk of ventricular arrhythmias					Drug Num: 35
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0025		Adenosine	C10H13N5O4	60961	Major		Inter Info	[5], [3], [6], [7], [8], [9], [10], [11]
D0107		Arsenic trioxide	As2O3	14888	Major		Inter Info	[28], [29]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[1], [2], [3], [88], [89]
D0868		Ivabradine	C27H36N2O5	132999	Major		Inter Info	[3], [124], [125]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[139]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Major		Inter Info	[153], [154], [155]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Major		Inter Info	[153], [154], [155]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[2], [163]
D1488		Sodium sulfate	Na2O4S	24436	Major		Inter Info	[153], [154], [155]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258]
D0184		Bisacodyl	C22H19NO4	2391	Moderate		Inter Info	[1], [2], [3], [267], [268], [269]
D0269		Castor oil	C57H104O9	14030006	Moderate		Inter Info	[1], [2], [3], [267], [268], [269]
D0516		Donepezil	C24H29NO3	3152	Moderate		Inter Info	[1], [2], [3], [280], [281], [282]
D0691		Formoterol	C19H24N2O4	3410	Moderate		Inter Info	[229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258]
D0701		Frangula purshiana bark	NA	NA	Moderate		Inter Info	[2], [3], [269]
D0707		Galantamine	C17H21NO3	9651	Moderate		Inter Info	[1], [2], [3], [280], [281], [282]
D0731		Glycerin	C3H8O3	753	Moderate		Inter Info	[1], [2], [3], [267], [268], [269]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258]
D0859		Isoprenaline	C11H17NO3	3779	Moderate		Inter Info	[242], [252], [255]
D0887		Lactitol	C12H24O11	157355	Moderate		Inter Info	[2], [3], [269]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[242], [252], [255]
D0970		Magnesium citrate	C12H10Mg3O14	6099959	Moderate		Inter Info	[1], [2], [3], [267], [268], [269]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[1], [2], [3], [267], [268], [269]
D1069		Mineral oil	NA	NA	Moderate		Inter Info	[1], [2], [3], [267], [268], [269]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258]
D1185		Orciprenaline	C11H17NO3	4086	Moderate		Inter Info	[242], [252], [255]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[242], [252], [255]
D1309		Polyethylene glycol (3350)	C2H6O2	174	Moderate		Inter Info	[2], [3], [269]
D1418		Rivastigmine	C14H22N2O2	77991	Moderate		Inter Info	[1], [2], [3], [280], [281], [282]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[242], [252], [255]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258]
D1554		Terbutaline	C12H19NO3	5403	Moderate		Inter Info	[229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[2], [3], [351]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[242], [252], [255]
D0888		Lactulose	C12H22O11	11333	Moderate		Inter Info	[1], [2], [3], [267], [268], [269]
Pharmacodynamic antagonistic effects
	Diminish the response to diagnostic skin test antigens					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1912		Trichophyton mentagrophytes	NA	NA	Moderate		Inter Info	[358], [162], [359]
D1913		Tuberculin purified protein derivative	NA	NA	Moderate		Inter Info	[358], [162], [359]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1807		Histamine	C5H9N3	774	Moderate		Inter Info	[126], [162], [297]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[3], [326], [162]
D1812		Hyaluronidase	C17H24BrNO2	91820602	Minor		Inter Info	[393], [347], [394]

References
1	Canadian Pharmacists Association.
2	Cerner Multum, Inc. "Australian Product Information.".
3	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
4	Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
5	Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7. [PMID: 7838793]
6	Teodorovich N, Margolin E, Kogan Y, Paz O, Swissa M. Torsades de pointes after adenosine administration. J Electrocardiol. 2016;49(2):171-173. [PMID: 26850499]
7	Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301. [PMID: 8131497]
8	Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10. [PMID: 15208219]
9	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
10	Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422. [PMID: 1392935]
11	Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6. [PMID: 1539535]
12	Maxa JL, Hebeler RF, Adeeko MA "Torsades de pointes following concurrent amiodarone and levofloxacin therapy." Proc (Bayl Univ Med Cent) 19 (2006): 345-6. [PMID: 17106497]
13	Product Information. Betapace (sotalol). Berlex, Richmond, CA.
14	Product Information. Cordarone (amiodarone). Wyeth-Ayerst Laboratories, Philadelphia, PA.
15	Product Information. Norpace (disopyramide). Searle, Skokie, IL.
16	Product Information. Procan SR (procainamide). Parke-Davis, Morris Plains, NJ.
17	Product Information. Quiniglute (quinidine). Berlex, Richmond, CA.
18	Product Information. Vascor (bepridil). McNeil Pharmaceutical, Raritan, NJ.
19	Trujillo TC, Nolan PE "Antiarrhythmic agents - Drug interactions of clinical significance." Drug Safety 23 (2000): 509-32. [PMID: 11144659]
20	Yamreudeewong W, DeBisschop M, Martin L, Lower D "Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs." Drug Saf 26 (2003): 421-38. [PMID: 12688833]
21	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
22	Product Information. Barhemsys (amisulpride). Acacia Pharma, Inc, Indianapolis, IN.
23	Gonzalez MA, Estes KS "Pharmacokinetic overview of oral second-generation H-1 antihistamines." Int J Clin Pharmacol Ther 36 (1998): 292-300. [PMID: 9629995]
24	Rao KA, Adlakha A, Vermaansil B, Meloy TD, Stanton MS "Torsades de pointes ventricular tachycardia associated with overdose of astemizole." Mayo Clin Proc 69 (1994): 589-93. [PMID: 8189766]
25	Tsai WC, Tsai LM, Chen JH "Combined use of astemizole and ketoconazole resulting in torsade de pointes." J Formos Med Assoc 96 (1997): 144-6. [PMID: 9071844]
26	Product Information. Emend (aprepitant). Merck & Company Inc, West Point, PA.
27	Product Information. Emend for Injection (fosaprepitant). Merck & Company Inc, West Point, PA.
28	Ohnishi K, Yoshida H, Shigeno K, et al. "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia." Ann Intern Med 133 (2000): 881-5. [PMID: 11103058]
29	Product Information. Trisenox (arsenic trioxide) Cephalon Inc, West Chester, PA.
30	Ament PW, Paterson A "Drug interactions with the nonsedating antihistamines." Am Fam Physician 56 (1997): 223. [PMID: 9225677]
31	Biglin KE, Faraon MS, Constance TD, Lieh-Lai M "Drug-induced torsades de pointes: a possible interaction of terfenadine and erythromycin." Ann Pharmacother 28 (1994): 282. [PMID: 8173153]
32	Craft TM "Torsade de pointes after astemizole overdose." Br Med J 292 (1986): 660. [PMID: 2868774]
33	Crane JK, Shih HT "Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine." Am J Med 95 (1993): 445-6. [PMID: 8213879]
34	Dresser GK, Spence JD, Bailey DG "Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition." Clin Pharmacokinet 38 (2000): 41-57. [PMID: 10668858]
35	DuBuske LM "Second-generation antihistamines: the risk of ventricular arrhythmias." Clin Ther 21 (1999): 281-95. [PMID: 10211532]
36	Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences [published correction appears in JAMA 1993 Apr 28;269(16):2088]. JAMA. 1993;269(12):1513-1518. [PMID: 8445813]
37	Hasan RA, Zureikat GY, Nolan BM "Torsade de pointes associated with astemizole overdose treated with magnesium sulfate." Pediatr Emerg Care 9 (1993): 23-5. [PMID: 8488140]
38	Heidemann SM, Sarnaik AP "Arrhythmias after astemizole overdose." Pediatr Emerg Care 12 (1996): 102-4. [PMID: 8859918]
39	Hey JA, Delprado M, Egan RW, Kreutner W "Terfenadine, astemizole, and ebastine produce QTc interval prolongation in an experimental model predictive of adverse clinical ECG effects." Ann Allergy Asthma Immunol 76 (1996): 476. [PMID: 8630724]
40	Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR Jr "Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin." Clin Pharmacol Ther 52 (1992): 231-8. [PMID: 1526078]
41	Honig PK, Wortham DC, Hull R, Zamani K, Smith JE, Cantilena LR "Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics." J Clin Pharmacol 33 (1993): 1201-6. [PMID: 8126255]
42	Honig PK, Wortham DC, Zamani K, et al "Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences." JAMA 269 (1993): 1513-8. [PMID: 8445813]
43	Jurima-Romet M, Crawford K, Cyr T, Inaba T "Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals." Drug Metab Dispos 22 (1994): 849-57. [PMID: 7895601]
44	Kivisto KT, Neuvonen PJ, Klotz U "Inhibition of terfenadine metabolism - pharmacokinetic and pharmacodynamic consequences." Clin Pharmacokinet 27 (1994): 1-5. [PMID: 7955768]
45	Mangum EM, Graham KK "Lopinavir-Ritonavir: a new protease inhibitor." Pharmacotherapy 21 (2001): 1352-63. [PMID: 11714208]
46	Mathews DR, McNutt B, Okerholm R, et al "Torsades de pointes occurring in association with terfenadine use." JAMA 266 (1991): 2375-6. [PMID: 1920744]
47	Ng PW, Chan WK, Chan TYK "Torsade de pointes during the concomitant use of terfenadine and cimetidine." Aust N Z J Med 26 (1996): 120-1. [PMID: 8775544]
48	Paris DG, Parente TF, Bruschetta HR, Guzman E, Niarchos AP "Torsades-de-pointes induced by erythromycin and terfenadine." Am J Emerg Med 12 (1994): 636-8. [PMID: 7945604]
49	Pohjola-Sintonen S, Viitasalo M, Toivonene L, Neuvonen P "Torsades de pointes after terfenadine-itraconazole interaction." BMJ 306 (1993): 186. [PMID: 8382980]
50	Product Information. Agenerase (amprenavir). Glaxo Wellcome, Research Triangle Pk, NC.
51	Product Information. Crixivan (indinavir). Merck & Co, Inc, West Point, PA.
52	Product Information. Fortovase (saquinavir) Roche Laboratories, Nutley, NJ.
53	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
54	Product Information. Lexiva (fosamprenavir). GlaxoSmithKline, Research Triangle Park, NC.
55	Product Information. Norvir (ritonavir). Abbott Pharmaceutical, Abbott Park, IL.
56	Product Information. Prezista (darunavir). Ortho Biotech Inc, Bridgewater, NJ.
57	Product Information. Reyataz (atazanavir). Bristol-Myers Squibb, Princeton, NJ.
58	Product Information. Viracept (nelfinavir). Agouron Pharma Inc, La Jolla, CA.
59	Rankin AC "Non-sedating antihistamines and cardiac arrhythmia." Lancet 350 (1997): 1115-6. [PMID: 9343494]
60	Saviuc P, Danel V, Dixmerias F "Prolonged QT interval and torsade de pointes following astemizole overdose." J Toxicol Clin Toxicol 31 (1993): 121-5. [PMID: 8433408]
61	Smith SJ "Cardiovascular toxicity of antihistamines." Otolaryngol Head Neck Surg 111 Suppl (1994): 348-54. [PMID: 7916150]
62	Snook J, Boothman-Burrell D, Watkins J, Colin-Jones D "Torsade de pointes ventricular tachycardia associated with astemizole overdose." Br J Clin Pract 42 (1988): 257-9. [PMID: 2905156]
63	Vorperian VR, Zhou ZF, Mohammad S, Hoon TJ, Studenik C, January CT "Torsade de pointes with an antihistamine metabolite: potassium channel blockade with desmethylastemizole." J Am Coll Cardiol 28 (1996): 1556-61. [PMID: 8917271]
64	Woosley RL "Cardiac actions of antihistamines." Annu Rev Pharmacol Toxicol 36 (1996): 233-52. [PMID: 8725389]
65	Zimmermann M, Duruz H, Guinand O, et al "Torsades de Pointes after treatment with terfenadine and ketoconazole." Eur Heart J 13 (1992): 1002-3. [PMID: 1644069]
66	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
67	Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
68	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
69	Amsden GW "Macrolides versus azalides: a drug interaction update." Ann Pharmacother 29 (1995): 906-17. [PMID: 8547740]
70	Brannan MD, Reidenberg P, Radwanski E, et al "Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations." Clin Pharmacol Ther 58 (1995): 269-78. [PMID: 7554700]
71	Cortese LM, Bjornson DC "Potential interaction between terfenadine and macrolide antibiotics." Clin Pharm 11 (1992): 675. [PMID: 1511540]
72	Harris S, Hilligoss DM, Colangelo PM, Eller M, Okerholm R "Azithromycin and terfenadine: lack of drug interaction." Clin Pharmacol Ther 58 (1995): 310-5. [PMID: 7554704]
73	Hsieh MH, Chen SA, Chiang CE, et al. "Drug-induced torsades de pointes in one patient with congenital long QT syndrome." Int J Cardiol 54 (1996): 85-8. [PMID: 8792191]
74	Kemp JP "Decreased antihistamine metabolism." Ann Allergy 69 (1992): 533. [PMID: 1361723]
75	Nahata M "Drug interactions with azithromycin and the macrolides: an overview." J Antimicrob Chemother 37 ( Suppl (1996): 133-42. [PMID: 8818854]
76	Product Information. Hismanal (astemizole). Janssen Pharmaceutica, Titusville, NJ.
77	European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products "European Public Assessment Report Ketek (telithromycin) (Rev. 2) ".
78	Product Information. Vaprisol (conivaptan). Cumberland Pharmaceuticals Inc, Nashville, TN.
79	Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
80	Bailey DG, Dresser GR, Kreeft JH, Munoz C, Freeman DJ, Bend JR "Grapefruit-felodipine interaction: Effect of unprocessed fruit and probable active ingredients." Clin Pharmacol Ther 68 (2000): 468-77. [PMID: 11103749]
81	Product Information. Synercid (dalfopristin-quinupristin) Rhone-Poulenc Rorer, Collegeville, PA.
82	Product Information. Rescriptor (delavirdine). Pharmacia and Upjohn, Kalamazoo, MI.
83	Product Information. Anzemet (dolasetron). Hoechst Marion-Roussel Inc, Kansas City, MO.
84	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
85	Castro VM, Clements CC, Murphy SN, et al. "QT interval and antidepressant use: a cross sectional study of electronic health records." BMJ 346 (2013): f288. [PMID: 23360890]
86	Do A, Noohi S, Elie D, et al. Health Canada Warning on Citalopram and Escitalopram--Its Effects on Prescribing in Consultation-Liaison Psychiatry.?Psychosomatics. 2016;57(1):57-63. [PMID: 26633294]
87	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
88	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
89	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
90	Ansari SR, Chopra N "Gatifloxacin and Prolonged QT Interval." Am J Med Sci 327 (2004): 55-6. [PMID: 14722399]
91	Siepmann M, Kirch W "Drug points - Tachycardia associated with moxifloxacin." Br Med J 322 (2001): 23. [PMID: 11141146]
92	Harper KM, Knapp DJ, Criswell HE, Breese GR "Vasopressin and alcohol: A multifaceted relationship." Psychopharmacology (Berl) 235 (2018): 3363-79. [PMID: 32936259]
93	Javelot H, El-Hage W, Meyer G, Becker G, Michel B, Hingray C "COVID-19 and (hydroxy)chloroquine-azithromycin combination: should we take the risk for our patients?" Br J Clin Pharmacol Apr 29 (2020): epub ahead of print. [PMID: 32350872]
94	National Institutes of Health (NIH) "Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.".
95	Product Information. Chloroquine Phosphate (chloroquine). West-Ward Pharmaceutical Corporation, Eatontown, NJ.
96	Product Information. Hydroxychloroquine Sulfate (hydroxychloroquine). Prasco Laboratories, Cincinnati, OH.
97	Product Information. Plaquenil (R). (hydroxychloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
98	Roden DM, Harrington RA, Poppas A, Russo AM "Considerations for drug interactions on QTc in exploratory COVID-19 (Coroanvirus disease 2019) treatment." Heart Rhythm Apr 14 (2020): epub ahead of print. [PMID: 32302703]
99	Sacher F, Fauchier L, Boveda S, et.al "Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection." Arch Cardiovasc Dis Apr 24 (2020): epub ahead of print. [PMID: 32354666]
100	Saleh M, Gabriels J, ChangD, et.al "The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection." Circ Arrhythm Electrophysiol Apr 29 (2020): epub ahead of print. [PMID: 32347743]
101	Sapp JL, Alqarawi W, MacIntyre CJ, et.al "Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: A statement from the Canadian Heart Rhythm Society." Can J Cardiol Apr 8 (2020): epub ahead of print. [PMID: 32299753]
102	Smit C, Peeters MYM, van den Anker JN, Knibbe CAJ "Chloroquine for SARS-CoV-2: Implications of its unique pharmacokinetic and safety properties." Clin Pharmacokinet Ar 18 (2020): epub ahead of print. [PMID: 32306288]
103	Bessiere F, Roccia H, Deliniere A, et.al "Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit." JAMA Cardiol May 1 (2020): epub ahead of print. [PMID: 32936266]
104	Borba MGS, Val FFA, Sampaio VS, et.al "Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 1 (SARS-CoV-2) infection: A randomized clinical trial." JAMA Netw Open Apr 1 (2020): epub ahead of print. [PMID: 32330277]
105	Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ "Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)" Mayo Clin Proc Apr 7 (2020): epub ahead of print. [PMID: 32359771]
106	Kapoor A, Pandurangi U, Arora V, et.al "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society." Indian Pacing Electorphysiol J Apr 8 (2020): epub ahead of print. [PMID: 32278018]
107	Mercuro NJ, Yen CF, Shim DJ, et.al "Risk of QT interval prolongation associated with the use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)" JAMA Cardiol May 1:e201834 (2020): epub ahead of print. [PMID: 32936252]
108	mitra RL, Greenstein SA, Epstein lm "An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin Possible benefits of intravenous lidocaine." HeartRythm Case Rep Apr 1 (2020): epub ahead of print. [PMID: 32363145]
109	US Food and Drug Administration "FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF CHLOROQUINE PHOSPHATE SUPPLIED FROM THE STRATEGIC NATIONAL STOCKPILE FOR TREATMENT OF COVID-19 IN CERTAIN HOSPITALIZED PATIENTS. Available from: URL: https://www.fda.gov/media/13653" ([2020, Apr 27]):.
110	US Food and Drug Administration "Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems.".
111	Product Information. Exforge HCT (amlodipine/hydrochlorothiazide/valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
112	Berul CI, Morad M "Regulation of potassium channels by nonsedating antihistamines." Circulation 91 (1995): 2220-5. [PMID: 7697852]
113	Goss JE, Ramo BW, Blake K "Torsades de pointes associated with astemizole (hismanal) therapy." Arch Intern Med 153 (1993): 2705. [PMID: 8250668]
114	Honig PK, Cantilena LR "Ketoconazole and fluconazole drug interactions." Arch Intern Med 154 (1994): 1038-41. [PMID: 8179450]
115	Pratt CM, Mason J, Russell T, Reynolds R, Ahlbrandt R "Cardiovascular safety of fexofenadine HCl." Am J Cardiol 83 (1999): 1451-4. [PMID: 10335761]
116	Product Information. Diflucan (fluconazole). Roerig Division, New York, NY.
117	Product Information. Nizoral (ketoconazole). Janssen Pharmaceutica, Titusville, NJ. (1992):.
118	Product Information. Noxafil (posaconazole). Schering-Plough Corporation, Kenilworth, NJ.
119	Product Information. Sporonox (itraconazole). Janssen Pharmaceutica, Titusville, NJ.
120	Product Information. VFEND (voriconazole). Pfizer U.S. Pharmaceuticals, New York, NY.
121	Salata JJ, Jurkiewicz NK, Wallace AA, Stupienski RF, Guinosso PJ, Lynch JJ "Cardiac electrophysiological actions of the histamine h-1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine." Circ Res 76 (1995): 110-9. [PMID: 8001268]
122	Simons FE, Kesselman MS, Giddins NG, Pelech AN, Simons KJ "Astemizole-induced torsade de pointes." Lancet 2 (1988): 624. [PMID: 2900995]
123	Venkatakrishnan K, von Moltke LL, Greenblatt DJ "Effects of the antifungal agents on oxidative drug metabolism: clinical relevance." Clin Pharmacokinet 38 (2000): 111-80. [PMID: 10709776]
124	Mittal SR "Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine." J Assoc Physicians India 62 (2014): 426-7. [PMID: 25438492]
125	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
126	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
127	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
128	Product Information. Fareston (toremifene). Schering Laboratories, Kenilworth, NJ.
129	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
130	Therapeutic Research Faculty "Natural Medicines Comprehensive Database.".
131	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
132	Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
133	Product Information. Serentil (mesoridazine) Boehringer-Ingelheim, Ridgefield, CT.
134	He K, Woolf TF, Hollenberg PF "Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486)." J Pharmacol Exp Ther 288 (1999): 791-7. [PMID: 9918590]
135	Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
136	Product Information. Mifeprex (mifepristone) Danco Laboratories, New York, NY.
137	Product Information. Serzone (nefazodone). Bristol-Myers Squibb, Princeton, NJ.
138	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
139	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
140	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
141	Goto M, Sato M, Kitzazawa H, et.al "Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation." Intern Med 53 (2014): 1629-31. [PMID: 25088875]
142	Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y "QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine." Cardiology 84 (1994): 9-13. [PMID: 7511988]
143	Jain A, Jenkins MG "Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine." Cathet Cardiovasc Diagn 18 (1989): 255-7. [PMID: 2605630]
144	Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T "Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve." Cathet Cardiovasc Diagn 19 (1990): 229-36. [PMID: 2334953]
145	Nakayama M, Saito A, Kitazawa H, et.al "Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases." Intern Med 51 (2012): 351-6. [PMID: 22333368]
146	Nakayama M, Tanaka N, Sakoda K, et.al "Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease." Circ J 79 (2015): 530-6. [PMID: 25746536]
147	Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML "Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine." J Am Coll Cardiol 15 (1990): 275-8. [PMID: 2299067]
148	Vrolix M, Piessens J, De Geest H "Torsades de pointes after intracoronary papaverine." Eur Heart J 12 (1991): 273-6. [PMID: 2044564]
149	Marchiando RJ, Cook MD "Probable terfenadine-fluoxetine-associated cardiac toxicity." Ann Pharmacother 29 (1995): 937-8. [PMID: 8547749]
150	Swims MP "Potential terfenadine-fluoxetine interaction." Ann Pharmacother 27 (1993): 1404-5. [PMID: 8286821]
151	Vonmoltke LL, Greenblatt DJ, Duan SX, Harmatz JS, Wright CE, Shader RI "Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo." J Clin Psychopharmacol 16 (1996): 104-12. [PMID: 8690825]
152	Product Information. Signifor (pasireotide). Novartis Pharmaceuticals, East Hanover, NJ.
153	Hill AG, Parry BR "Hypokalaemia following bowel cleansing with sodium phosphate." N Z Med J 109 (1996): 347. [PMID: 8862361]
154	Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
155	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
156	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
157	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
158	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
159	Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
160	Witchel HJ, Hancox JC, Nutt DJ "Psychotropic drugs, cardiac arrhythmia, and sudden death." J Clin Psychopharmacol 23 (2003): 58-77. [PMID: 12544377]
161	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
162	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
163	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
164	Liberatore MA, Robinson DS "Torsade de pointes: a mechanism for sudden death associated with neuroleptic drug therapy?" J Clin Psychopharmacol 4 (1984): 143-6. [PMID: 6145728]
165	Product Information. Mellaril (thioridazine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
166	Product Information. Vandetanib (vandetanib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
167	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
168	Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR "Effect of concomitant administration of cimetidine and ranitidine on the pharmacokinetics and electrocardiographic effects of terfenadine." Eur J Clin Pharmacol 45 (1993): 41-6. [PMID: 8405028]
169	Woosley R, Carrow WR "Analysis of potential adverse drug reactions--a case of mistaken identity." Am J Cardiol 74 (1994): 208-9. [PMID: 8023797]
170	Woosley RL, Chen Y, Freiman JP, Gillis RA "Mechanism of the cardiotoxic actions of terfenadine." JAMA 269 (1993): 1532-6. [PMID: 8445816]
171	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).".
172	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
173	Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
174	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
175	Product Information. Inapsine (droperidol). Janssen Pharmaceutica, Titusville, NJ.
176	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
177	Product Information. Luvox (fluvoxamine). Solvay Pharmaceuticals Inc, Marietta, GA.
178	Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Matsuzaki I, Yonezawa Y "The association between intravenous haloperidol and prolonged QT interval." J Clin Psychopharmacol 21 (2001): 257-61. [PMID: 11386487]
179	Huyse F, van Schijndel RS "Haloperidol and cardiac arrest." Lancet 2 (1988): 568-9. [PMID: 2900948]
180	Metzger E, Friedman R "Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill." J Clin Psychopharmacol 13 (1993): 128-32. [PMID: 8463445]
181	O'Brien JM, Rockwood RP, Suh KI "Haloperidol-induced torsade de pointes." Ann Pharmacother 33 (1999): 1046-9. [PMID: 10534216]
182	Product Information. Haldol (haloperidol). McNeil Pharmaceutical, Raritan, NJ.
183	Wilt JL, Minnema AM, Johnson RF, Rosenblum AM "Torsade de pointes associated with the use of intravenous haloperidol." Ann Intern Med 119 (1993): 391-4. [PMID: 8338292]
184	Product Information. Corvert (ibutilide). Pharmacia and Upjohn, Kalamazoo, MI.
185	De Bels D, Staroukine M, Devriendt J "Torsades de pointes due to methadone." Ann Intern Med 139 (2003): E156. [PMID: 12859181]
186	Ehret GB, Desmeules JA, Broers B "Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology." Expert Opin Drug Saf 6 (2007): 289-303. [PMID: 17480178]
187	Gil M, Sala M, Anguera I, et al. "QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone." Am J Cardiol 92 (2003): 995-7. [PMID: 14556883]
188	Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS "Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes." Pharmacotherapy 23 (2003): 802-5. [PMID: 12820821]
189	Krantz MJ, Lewkowiez L, Hays H, et al "Torsade de pointes associated with very-high-dose methadone." Ann Intern Med 137 (2002): 501-4. [PMID: 12230351]
190	Krantz MJ, Mehler PS "Synthetic opioids and QT prolongation." Arch Intern Med 163 (2003): 1615 author reply 1615. [PMID: 12860589]
191	Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN "Impact of methadone treatment on cardiac repolarization and conduction in opioid users." Am J Cardiol 95 (2005): 915-8. [PMID: 15781034]
192	Mokwe EO, Ositadinma O "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966000]
193	Sala M, Anguera I, Cervantes M "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966001]
194	Walker PW, Klein D, Kasza L "High dose methadone and ventricular arrhythmias: a report of three cases." Pain 103 (2003): 321-4. [PMID: 12791438]
195	Ball P "Quinolone-induced QT interval prolongation: a not-so-unexpected class effect." J Antimicrob Chemother 45 (2000): 557-9. [PMID: 10797074]
196	Bertino JS Jr, Owens RC Jr, Carnes TD, Iannini PB "Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors." Clin Infect Dis 34 (2002): 861-3. [PMID: 11830802]
197	Dale KM, Lertsburapa K, Kluger J, White CM "Moxifloxacin and torsade de pointes." Ann Pharmacother 41 (2007): 336-40. [PMID: 17284508]
198	Demolis JL, Kubitza D, Tenneze L, Funck-Bretano C "Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects." Clin Pharmacol Ther 68 (2000): 658-66. [PMID: 11180026]
199	Falagas ME, Rafailidis PI, Rosmarakis ES "Arrhythmias associated with fluoroquinolone therapy." Int J Antimicrob Agents 29 (2007): 374-9. [PMID: 17241772]
200	Frothingham R "Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin." Pharmacotherapy 21 (2001): 1468-72. [PMID: 11765299]
201	Iannini PB, Circiumaru I "Gatifloxacin-induced QTc prolongation and ventricular tachycardia." Pharmacotherapy 21 (2001): 361-2. [PMID: 11253862]
202	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs." BMJ 322 (2001): 46-7. [PMID: 11141163]
203	Kang J, Wang L, Chen XL, Triggle DJ, Rampe D "Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG." Mol Pharmacol 59 (2001): 122-6. [PMID: 11125032]
204	Katritsis D, Camm AJ "Quinolones: cardioprotective or cardiotoxic." Pacing Clin Electrophysiol 26 (2003): 2317-20. [PMID: 14675020]
205	Noel GJ, Natarajan J, Chien S, Hunt TL, Goodman DB, Abels R "Effects of three fluoroquinolones on QT interval in healthy adults after single doses." Clin Pharmacol Ther 73 (2003): 292-303. [PMID: 12709719]
206	Oliphant CM, Green GM "Quinolones: a comprehensive review." Am Fam Physician 65 (2002): 455-64. [PMID: 11858629]
207	Owens RC "QT Prolongation with Antimicrobial Agents : Understanding the Significance." Drugs 64 (2004): 1091-124. [PMID: 15139788]
208	Owens RC "Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes." Pharmacotherapy 21 (2001): 301-19. [PMID: 11253855]
209	Owens RC Jr, Ambrose PG "Torsades de pointes associated with fluoroquinolones." Pharmacotherapy 22 (2002): 663-8 discussion 668-72. [PMID: 12013370]
210	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
211	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
212	Stahlmann R "Clinical toxicological aspects of fluoroquinolones." Toxicol Lett 127 (2002): 269-77. [PMID: 12052667]
213	Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF "Effects of three fluoroquinolones on QT analysis after standard treatment courses." Ann Noninvasive Electrocardiol 11 (2006): 52-6. [PMID: 16472283]
214	White CM, Grant EM, Quintiliani R "Moxifloxacin does increase the corrected QT interval." Clin Infect Dis 33 (2001): 1441-2. [PMID: 11565091]
215	Martin ES, Rogalski K, Black JN "Quinine may trigger torsades de pointes during astemizole therapy." Pacing Clin Electrophysiol 20 (1997): 2024-5. [PMID: 9272545]
216	Feroze H, Suri R, Silverman DI "Torsades de pointes from terfenadine and sotalol given in combination." Pacing Clin Electrophysiol 19 (1996): 1519-21. [PMID: 8904547]
217	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
218	Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.
219	Product Information. Uroxatral (alfuzosin). sanofi-aventis , Bridgewater, NJ.
220	Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
221	Product Information. Eligard (leuprolide). Sanofi Winthrop Pharmaceuticals, New York, NY.
222	Product Information. Firmagon (degarelix). Ferring Pharmaceuticals Inc, Tarrytown, NY.
223	Product Information. Lupron (leuprolide). TAP Pharmaceuticals Inc, Deerfield, IL.
224	Product Information. Plenaxis (abarelix). Praecis Pharmaceuticals Inc, Waltham, MA.
225	Product Information. Trelstar (triptorelin) Pharmacia and Upjohn, Kalamazoo, MI.
226	Product Information. Vantas (histrelin). Endo Pharmaceuticals (formally Indevus Pharmaceuticals Inc), Lexington, MA.
227	Product Information. Zoladex (goserelin). Zeneca Pharmaceuticals, Wilmington, DE.
228	Product Information. Apokyn (apomorphine). Mylan Pharmaceuticals Inc, Morgantown, WV.
229	Bengtsson B, Fagerstrom PO "Extrapulmonary effects of terbutaline during prolonged administration." Clin Pharmacol Ther 31 (1982): 726-32. [PMID: 7042176]
230	Braden GL, vonOeyen PT, Germain MJ, Watson DJ, Haag BL "Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences." Kidney Int 51 (1997): 1867-75. [PMID: 9186877]
231	Clifton GD, Hunt BA, Patel RC, Burki NK "Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses." Am Rev Respir Dis 141 (1990): 575-9. [PMID: 2178522]
232	Dickens GR, Mccoy RA, West R, Stapczynski JS, Clifton GD "Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease." Pharmacotherapy 14 (1994): 729-33. [PMID: 7885977]
233	Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C "Cardiovascular Safety of Salmeterol in COPD." Chest 123 (2003): 1817-24. [PMID: 12796155]
234	Gelmont DM, Balmes JR, Yee A "Hypokalemia induced by inhaled bronchodilators." Chest 94 (1988): 763-6. [PMID: 3168573]
235	Gross TL, Sokol RJ "Severe hypokalemia and acidosis: a potential complication of beta- adrenergic treatment." Am J Obstet Gynecol 138 (1980): 1225-6. [PMID: 7446635]
236	Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9. [PMID: 708661]
237	Hurlbert BJ, Edelman JD, David K "Serum potassium levels during and after terbutaline." Anesth Analg 60 (1981): 723-5. [PMID: 7197475]
238	Hypokalaemia due to salbutamol overdosage. Br Med J (Clin Res Ed) 283 (1981): 500-1. [PMID: 6114774]
239	Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20. [PMID: 3956296]
240	Lowe MD, Rowland E, Brown MJ, Grace AA "Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium." Heart 86 (2001): 45-51. [PMID: 11410561]
241	Milic M, Bao X, Rizos D, Liu F, Ziegler MG "Literature review and pilot studies of the effect of qt correction formulas on reported beta(2)-agonist-induced QTc prolongation." Clin Ther 28 (2006): 582-90. [PMID: 16750469]
242	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
243	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
244	Product Information. Brovana (arformoterol). Sepracor Inc, Marlborough, MA.
245	Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
246	Product Information. Maxair (pirbuterol). 3M Pharmaceuticals, St. Paul, MN.
247	Product Information. Proventil (albuterol). Schering Laboratories, Kenilworth, NJ.
248	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
249	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
250	Product Information. Xopenex (levalbuterol). Sepracor, Marlborough, MA.
251	Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7. [PMID: 9583400]
252	Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA "Metabolic and cardiovascular effects of carbuterol and metaproterenol." J Allergy Clin Immunol 60 (1977): 174-9. [PMID: 19514]
253	Sun ZH, Swan H, Vitasalo M, Toivonen L "Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome." J Am Coll Cardiol 31 (1998): 1400-5. [PMID: 9581741]
254	Tveskov C, Djurhuus MS, Klitgaard NAH, Egstrup K "Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta(2)-adrenergic stimulation with terbutaline in healthy subjects." Chest 106 (1994): 1654-9. [PMID: 7988180]
255	Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71. [PMID: 3545273]
256	Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R "A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol." N Z Med J 103 (1990): 259-61. [PMID: 1972557]
257	Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9. [PMID: 1978872]
258	Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9. [PMID: 921062]
259	Goodnick PJ, Jerry J, Parra F "Psychotropic drugs and the ECG: focus on the QTc interval." Expert Opin Pharmacother 3 (2002): 479-98. [PMID: 11996627]
260	Kane JM, Carson WH, Saha AR, et al. "Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder." J Clin Psychiatry 63 (2002): 763-71. [PMID: 12363115]
261	Keck PE Jr, Marcus R, Tourkodimitris S, et al. "A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania." Am J Psychiatry 160 (2003): 1651-8. [PMID: 12944341]
262	Nelson S, Leung JG "Torsades de Pointes After Administration of Low-Dose Aripiprazole (February)." Ann Pharmacother (2013):. [PMID: 23362038]
263	Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG "Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study." J Clin Psychiatry 64 (2003): 1048-56. [PMID: 14628980]
264	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
265	Product Information. Saphris (asenapine). Schering-Plough Corporation, Kenilworth, NJ.
266	Product Information. Mektovi (binimetinib). Array BioPharma Inc., Boulder, CO.
267	Chin RL "Laxative-induced hypokalemia." Ann Emerg Med 32 (1998): 517-8. [PMID: 9774942]
268	Muller-Lissner SA "Adverse effects of laxatives: fact and fiction." Pharmacology 47 (1993): 138-45. [PMID: 8234421]
269	Schaefer DC, Cheskin LJ "Constipation in the elderly." Am Fam Physician 58 (1998): 907-14. [PMID: 9767726]
270	Abbas R, Hug BA, Leister C, Sonnichsen D "A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects." Int J Cancer 131 (2012): Epub. [PMID: 22065400]
271	Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
272	Product Information. Xcopri (cenobamate). SK Life Science, Inc., Paramus, NJ.
273	Product Information. Lamprene (clofazimine). Novartis Pharmaceuticals, East Hanover, NJ.
274	Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm 66 (2009): 1438-67. [PMID: 19667002]
275	Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
276	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
277	Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
278	Skerjanec A, Wang J, Maren K, Rojkjaer L "Investigation of the pharmacokinetic interactions of deferasirox, a once-daily oral iron chelator, with midazolam, rifampin, and repaglinide in healthy volunteers." J Clin Pharmacol 50 (2010): 205-13. [PMID: 19940232]
279	Product Information. Austedo (deutetrabenazine). Teva Pharmaceuticals USA, North Wales, PA.
280	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
281	Product Information. Exelon (rivastigmine) Novartis Pharmaceuticals, East Hanover, NJ.
282	Product Information. Razadyne (galantamine). Johnson and Johnson Medical Inc, Arlington, TX.
283	Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
284	Gorski JC, Huang SM, Pinto A, et al. "The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo." Clin Pharmacol Ther 75 (2004): 89-100. [PMID: 14749695]
285	Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
286	Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
287	Product Information. Balversa (erdafitinib). Janssen Products, LP, Horsham, PA.
288	Product Information. Halaven (eribulin). Eisai Inc, Teaneck, NJ.
289	Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
290	Product Information. Pepcid (famotidine). Merck & Co, Inc, West Point, PA.
291	Product Information. Inrebic (fedratinib). Celgene Corporation, Summit, NJ.
292	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
293	Product Information. Rukobia (fostemsavir). ViiV Healthcare, Research Triangle Park, NC.
294	Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
295	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
296	Product Information. Daurismo (glasdegib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
297	Product Information. Histatrol (histamine phosphate). Center Laboratories, Port Washington, NY.
298	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
299	Product Information. Rexulti (brexpiprazole). Otsuka American Pharmaceuticals Inc, Rockville, MD.
300	Product Information. Sodium Iodide I-123 (sodium iodide I-123). GE Healthcare, Princeton, NJ.
301	Product Information. Cresemba (isavuconazonium). Astellas Pharma US, Inc, Deerfield, IL.
302	Product Information. Kalydeco (ivacaftor). Vertex Pharmaceuticals, Cambridge, MA.
303	Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
304	Product Information. Prevymis (letermovir). Merck & Company Inc, Whitehouse Station, NJ.
305	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs. Prolongation of QT interval is probably a class effect of fluoroquinolones." Br Med J 322 (2001): 46-7. [PMID: 11141163]
306	Kahn JB "Latest industry information on the safety profile of levofloxacin in the US." Chemotherapy 47 Suppl 3 (2001): 32-7. [PMID: 11549787]
307	Makaryus AN, Byrns K, Makaryus MN, Natarajan U, Singer C, Goldner B "Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?" South Med J 99 (2006): 52-6. [PMID: 16466123]
308	Nykamp DL, Blackmon CL, Schmidt PE, Roberson AG "QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine." Ann Pharmacother 39 (2005): 543-6. [PMID: 15687478]
309	Product Information. Floxin (ofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
310	Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
311	Samaha FF "QTC interval prolongation and polymorphic ventricular tachycardia in association with levofloxacin." Am J Med 107 (1999): 528-9. [PMID: 10569314]
312	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
313	Product Information. Lucemyra (lofexidine). US WorldMeds LLC, Louisville , KY.
314	Product Information. Zokinvy (lonafarnib). Eiger BioPharmaceuticals, Palo Alto, CA.
315	Eggleston W, Clark KH, Marraffa JM "Loperamide abuse associated with cardiac dysrhythmia and death." Ann Emerg Med 69 (2017): 83-6. [PMID: 27140747]
316	US Food and Drug Administration "FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse.".
317	Product Information. Lorbrena (lorlatinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
318	Product Information. Akynzeo (netupitant-palonosetron). Eisai Inc, Woodcliff Lake, NJ.
319	Product Information. Akynzeo for Injection (fosnetupitant-palonosetron). Helsinn Therapeutics Inc, Woodbridge Township, NJ.
320	Product Information. Isturisa (osilodrostat). Recordati Rare Diseases Inc, Lebanon, NJ.
321	Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
322	Product Information. Ibrance (palbociclib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
323	Product Information. Sonata (zaleplon) Wyeth-Ayerst Laboratories, Philadelphia, PA.
324	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
325	Product Information. Nuplazid (pimavanserin). Accelis Pharma, East Windsor, NJ.
326	Product Information. Wakix (pitolisant). Harmony Biosciences, LLC, Plymouth Meeting, PA.
327	Hanci V, Aydin M, Yurtlu BS, et.al "Anesthesia induction with sevoflurane and propofol: evaluation of P-wave dispersion, QT and corrected QT intervals." Kaohsiung J Med Sci 26 (2010): 470-7. [PMID: 20837343]
328	Kim DH, Kweon TD, Nam SB, Han DW, Cho WY, Lee JS "Effects of target concentration infusion of propofol and tracheal intubation on QTc interval." Anaesthesia 63 (2008): 1061-4. [PMID: 18717665]
329	Kleinsasser A, Kuenszberg E, Loeckinger A, et.al "Sevoflurane, but not propofol, significantly prolongs the Q-T interval." Anesth Analg 90 (2000): 25-7. [PMID: 10624970]
330	Kleinsasser A, Loeckinger A, Lindner KH, Keller C, Boehler M, Puehringer F "Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol." Anaesthesia 56 (2001): 248-50. [PMID: 11251432]
331	Paventi S, Santevecchi A, Ranieri R "Effects of sevoflurane versus propofol on QT interval." Minerva Anestesiol 67 (2001): 637-40. [PMID: 11731753]
332	Scalese MJ, Herring HR, Rathburn RC, Skrepnek GH, Ripley TL "Propofol-associated QTc prolongation." Ther Adv Drug Saf 7 (2016): 68-78. [PMID: 27298717]
333	Staikou C, Stamelos M, Stavroulakis E "Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity." Br J Anaesth 112 (2014): 217-30. [PMID: 24305646]
334	Toyoda T, Terao Y, Oji M, Okada M, Fukusaki M, Sumikawa K "The interaction of antiemetic dose of droperidol with propofol on QT interval during anesthetic induction." J Anesth 27 (2013): 885-9. [PMID: 23660990]
335	Whyte SD, Booker PD, Buckley DG "The Effects of Propofol and Sevoflurane on the QT Interval and Transmural Dispersion of Repolarization in Children." Anesth Analg 100 (2005): 71-77. [PMID: 15616054]
336	Wutzler A, De Asmundis C, Matsuda H, et.al "Effects of propofol on ventricular repolarization and incidence of malignant arrhythmias in adults." J Electrocardiol 51 (2018): 170-4. [PMID: 29174097]
337	Product Information. Seroquel (quetiapine). Zeneca Pharmaceuticals, Wilmington, DE.
338	Sala M, Vicentini A, Brambilla P, et al. "QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy." Ann Gen Psychiatry 4 (2005): 1. [PMID: 15845138]
339	Vieweg WV "New generation antipsychotic drugs and QTc interval prolongation." Prim Care Companion J Clin Psychiatry 5 (2003): 205-15. [PMID: 15213787]
340	Vieweg WV, Schneider RK, Wood MA "Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine." Acta Psychiatr Scand 112 (2005): 318-22. [PMID: 16156840]
341	Product Information. Priftin (rifapentine). Hoechst Marion-Roussel Inc, Kansas City, MO.
342	Thijssen HH, Flin ois JP, Beaune PH "Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes." Drug Metab Dispos 28 (2000): 1284-90. [PMID: 11038154]
343	Product Information. Ultane (sevoflurane). Abbott Pharmaceutical, Abbott Park, IL.
344	Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
345	Product Information. Rapamune (sirolimus) Wyeth-Ayerst Laboratories, Philadelphia, PA.
346	Product Information. Sutent (sunitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
347	Gunston GD, Mehta U "Potentially serious drug interactions with grapefruit juice." S Afr Med J 90 (2000): 41. [PMID: 10721388]
348	Product Information. Tazverik (tazemetostat). Epizyme, Inc, Cambridge, MA.
349	Product Information. Xermelo (telotristat ethyl). Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
350	Product Information. Xenazine (tetrabenazine). Prestwick Pharmaceuticals Inc, Washington DC, VA.
351	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
352	Product Information. Brilinta (ticagrelor). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
353	Antonelli D, Atar S, Freedberg NA, Rosenfeld T "Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions." Isr Med Assoc J 7 (2005): 163-5. [PMID: 15792261]
354	Dattilo PB, Nordin C "Prolonged QT associated with an overdose of trazodone." J Clin Psychiatry 68 (2007): 1309-10. [PMID: 17854263]
355	Levenson JL "Prolonged QT interval after trazodone overdose." Am J Psychiatry 156 (1999): 969-70. [PMID: 10360146]
356	Mazur A, Strasberg B, Kusniec J, Sclarovsky S "QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination." Int J Cardiol 52 (1995): 27-9. [PMID: 8707432]
357	Product Information. Oleptro (traZODone). Labopharm Inc, Laval, AL.
358	Multum Information Services, Inc. Expert Review Panel.
359	NLM. National Library of Medicine. NIH. National Institutes of Health "Trichophyton for intradermal skin testing (trichophyton mentagrophytes and trichophyton rubrum) injection.".
360	Ace LN, Jaffe JM, Kunka RL "Effect of food and an antacid on quinidine bioavailability." Biopharm Drug Dispos 4 (1983): 183-90. [PMID: 6882885]
361	Min DI, Ku YM, Geraets DR, Lee HC "Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers." J Clin Pharmacol 36 (1996): 469-76. [PMID: 8739026]
362	Product Information. Tukysa (tucatinib). Seattle Genetics Inc, Bothell, WA.
363	Product Information. Ingrezza (valbenazine). Neurocrine Biosciences, Inc., San Diego, CA.
364	Bailey DG, Arnold JMO, Spence JD "Grapefruit juice and drugs - how significant is the interaction." Clin Pharmacokinet 26 (1994): 91-8. [PMID: 8162660]
365	Product Information. Oxbryta (voxelotor). Global Blood Therapeutics, Inc., South San Francisco, CA.
366	Product Information. Zylo Filmtab (zileuton). Abbott Pharmaceutical, Abbott Park, IL.
367	Product Information. Targretin (bexarotene) Ligand Pharmaceuticals, San Diego, CA.
368	Wakelee HA, Takimoto CH, Lopez-Anaya A, et al. "The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer." Cancer Chemother Pharmacol 69 (2012): 563-71. [PMID: 22057855]
369	Product Information. Tracleer (bosentan). Acetelion Pharmaceuticals US, Inc, South San Francisco, CA.
370	Abernethy DR, Egan JM, Dickinson TH, Carrum G "Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans." J Pharmacol Exp Ther 244 (1988): 994-9. [PMID: 3252045]
371	Renton KW "Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil." Biochem Pharmacol 34 (1985): 2549-53. [PMID: 4015695]
372	Sakai H, Kobayashi S, Hamada K, et al "The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates." Br J Clin Pharmacol 31 (1991): 353-5. [PMID: 2054276]
373	Sutton D, Butler AM, Nadin L, Murray M "Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites." J Pharmacol Exp Ther 282 (1997): 294-300. [PMID: 9223567]
374	Varis T, Backman JT, Kivisto KT, Neuvonen PJ "Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone." Clin Pharmacol Ther 67 (2000): 215-21. [PMID: 10741623]
375	Product Information. Gleevec (imatinib mesylate). Novartis Pharmaceuticals, East Hanover, NJ.
376	Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
377	Canadian Pharmacists Association "e-CPS."
378	Product Information. Remeron (mirtazapine). Organon, West Orange, NJ.
379	Product Information. Viramune (nevirapine). Boehringer-Ingelheim, Ridgefield, CT.
380	Product Information. Viramune XR (nevirapine). Boehringer Ingelheim, Ridgefield, CT.
381	Product Information. Zyprexa (olanzapine). Lilly, Eli and Company, Indianapolis, IN.
382	Product Information. Definity (perflutren). Lantheus Medical Imaging Inc, North Billerica, MA.
383	Product Information. Optison (perflutren). Mallinckrodt Medical Inc, St. Louis, MO.
384	European Medicines Agency "CHMP Assessment Report for Latixa. International nonproprietary name: ranolazine.".
385	Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.
386	Product Information. Nexavar (sorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
387	Doherty MM, Charman WN "The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?" Clin Pharmacokinet 41 (2002): 235-53. [PMID: 11978143]
388	Product Information. Nuvigil (armodafinil). Cephalon Inc, West Chester, PA.
389	Product Information. Provigil (modafinil). Cephalon, Inc, West Chester, PA.
390	Robertson P Jr, Hellriegel ET, Arora S, Nelson M "Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers." Clin Pharmacol Ther 71 (2002): 46-56. [PMID: 11823757]
391	Robertson P, Decory HH, Madan A, Parkinson A "In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil." Drug Metab Dispos 28 (2000): 664-71. [PMID: 10820139]
392	Product Information. Dificid (fidaxomicin). Optimer Pharmaceuticals, San Diego, CA.
393	Fuhr U, Maier-Bruggemann A, Blume H, et al. "Grapefruit juice increases oral nimodipine bioavailability." Int J Clin Pharmacol Ther 36 (1998): 126-32. [PMID: 9562227]
394	Product Information. Vitrase (hyaluronidase). Bausch and Lomb, Rochester, NY.
395	Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F "QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone." Pacing Clin Electrophysiol 28 (2005): 472-3. [PMID: 15869686]
396	Product Information. Flagyl (metronidazole). Searle, Skokie, IL.
397	Product Information. Pylera (bismuth subcitrate potassium/metronidazo/TCN). Aptalis Pharma, Birmingham, AL.
398	Crouch MA, Limon L, Cassano AT "Clinical relevance and management of drug-related QT interval prolongation." Pharmacotherapy 23 (2003): 881-908. [PMID: 12885102]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence